Is there a role for PCSK9 inhibition in patients with high Lp(a)?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Lp(a), a new lipid frontier in CV risk management & target for therapyIntroduction: Lp(a), a new lipid frontier in CV risk management & target for therapy
Prof. Erik Stroes, MD
- Lp(a), a new lipid frontier in CV risk management & target for therapyNovel strategies to lower Lp(a)
Prof. Sam Tsimikas
- Lp(a), a new lipid frontier in CV risk management & target for therapyWhy worry about high Lp(a) and how to assess Lp(a) levels?
Pia Kamstrup, MD, PhD
